nach oben

Erschienen in:

18.11.2019 | Original Article

Investigating the route of administration and efficacy of adipose tissue-derived mesenchymal stem cells and conditioned medium in type 1 diabetic mice

verfasst von: Seyed Mahmoud Hashemi, Zuhair Mohammad Hassan, Nikoo Hossein-Khannazer, Ali Akbar Pourfathollah, Sara Soudi

Erschienen in: Inflammopharmacology | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Type 1 diabetes (T1D) is a chronic autoimmune disease destroying the insulin-producing beta cells. Recently, stem cell therapy has been tested to treat T1D. In the present study, we aim to investigate the effects of intraperitoneal and intravenous infusion of multipotent mesenchymal stem/stromal cells (MSCs) and MSC-conditioned medium (MSC-CM) in an experimental model of diabetes, induced by multiple injections of Streptozotocin (STZ). The adipose tissue-derived MSC and MSC-CM were isolated from C57Bl/6 male mice and characterized. Later, MSC and MSC-CM were injected intraperitoneally or intravenously into mice. The blood glucose, urinary glucose, and body weight were measured, and the percentages of CD4+ CD25+ FOXP3+ T cells as well as the levels of IFN-γ, TGF-β, IL-4, IL-17, and IL-10 were evaluated. Our results showed that both intraperitoneal and intravenous infusions of MSC and MSC-CM could decrease the blood glucose, recover pancreatic islets, and increase the levels of insulin-producing cells. Furthermore, the percentage of CD4+ CD25+ FOXP3+ T cells was increased after intraperitoneal injection of MSC or MSC-CM and intravenous injection of MSCs. After intraperitoneal injection of the MSC and MSC-CM, the levels of inflammatory cytokines reduced, while the levels of anti-inflammatory cytokines increased. Together current data showed that although both intraperitoneal and intravenous administration had beneficial effects on T1D animal model, but intraperitoneal injection of AD-MSC and AD-MSC-CM was more effective than systemic administration.

Abdi R, Fiorina P, Adra CN et al (2008) Immunomodulation by mesenchymal stem cells a potential therapeutic strategy for type 1 diabetes. Diabetes 57:1759–1767. https://doi.org/10.2337/db08-0180 CrossRefPubMedPubMedCentral

Aguayo-mazzucato C, Bonner-weir S (2010) Stem cell therapy for type 1 diabetes mellitus. Nat Rev Endocrinol 6:139–148. https://doi.org/10.1038/nrendo.2009.274 CrossRefPubMed

Alnek K, Kisand K, Heilman K et al (2015) Increased blood levels of growth factors, proinflammatory cytokines, and Th17 cytokines in patients with newly diagnosed type 1 diabetes. PLoS ONE. https://doi.org/10.1371/journal.pone.0142976 CrossRefPubMedPubMedCentral

Augello A, Tasso R, Negrini SM et al (2007) Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 56:1175–1186. https://doi.org/10.1002/art.22511 CrossRefPubMed

Bassi ÊJ, Moraes-Vieira PMM, Moreira-Sá CSR et al (2012) Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes. Diabetes 61:2534–2545. https://doi.org/10.2337/db11-0844 CrossRefPubMedPubMedCentral

Boumaza I, Srinivasan S, Witt WT et al (2009) Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia. J Autoimmun 32:33–42. https://doi.org/10.1016/j.jaut.2008.10.004 CrossRefPubMed

Brayman K (2016) Stem cell therapy to cure type 1 diabetes: from hype to hope stem cell therapy to cure type 1 diabetes : from hype to hope. Stem Cells Transl Med. https://doi.org/10.5966/sctm.2012-0116 CrossRef

Caplan AI, Sorrell JM (2015) The MSC curtain that stops the immune system. Immunol Lett. https://doi.org/10.1016/j.imlet.2015.06.005 CrossRefPubMed

Chen L, Jiang X, Yang L (2004) Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J Gastroenterol 10:3016–3020CrossRef

Chen QH, Liu AR, Qiu HB, Yang Y (2015) Interaction between mesenchymal stem cells and endothelial cells restores endothelial permeability via paracrine hepatocyte growth factor in vitro. Stem Cell Res Ther. https://doi.org/10.1186/s13287-015-0025-1 CrossRefPubMedPubMedCentral

Chhabra P, Brayman KL (2013) Stem cell therapy to cure type 1 diabetes: from hype to hope. Stem Cells Transl Med 2:328–336. https://doi.org/10.5966/sctm.2012-0116 CrossRefPubMedPubMedCentral

Ciccocioppo R, Cangemi GC, Kruzliak P et al (2015) Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn’s disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact. Stem Cell Res Ther. https://doi.org/10.1186/s13287-015-0122-1 CrossRefPubMedPubMedCentral

Djouad F, Charbonnier L-M, Bouffi C et al (2007) Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 25:2025–2032. https://doi.org/10.1634/stemcells.2006-0548 CrossRefPubMed

Du MM, Ritter T, Ceredig R, Gri MD (2011) Mesenchymal stem cell e ects on T-cell e ector pathways. Stem Cell Res Ther 2:1–9CrossRef

Figliuzzi M, Cornolti R, Perico N et al (2009) Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats. TPS 41:1797–1800. https://doi.org/10.1016/j.transproceed.2008.11.015 CrossRef

Fiorina P, Voltarelli J, Zavazava N et al (2011) Immunological Applications of Stem Cells in Type 1 Diabetes. Endocrine Reviews 32:725–754. https://doi.org/10.1210/er.2011-0008 CrossRefPubMedPubMedCentral

Gao F, Chiu SM, Motan DAL et al (2016) Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis. https://doi.org/10.1038/cddis.2015.327 CrossRefPubMedPubMedCentral

Ghionzoli M, Cananzi M, Zani A et al (2010) Amniotic fluid stem cell migration after intraperitoneal injection in pup rats: implication for therapy. Pediatr Surg Int. https://doi.org/10.1007/s00383-009-2504-x CrossRefPubMed

Heidari M, Aghdaei HA, Hashemi SM (2018) The immunomodulatory effects of adipose-derived mesenchymal stem cells and mesenchymal stem cells-conditioned medium in chronic colitis. J Cell Physiol 233:1–13. https://doi.org/10.1002/jcp.26765 CrossRef

Hossein-khannazer N, Hashemi SM, Namaki S et al (2019a) Research article: The effects of dental pulp stem cell conditioned media on the proliferation of peripheral blood mononuclear cells. Immunoregulation 1:187–192CrossRef

Hossein-khannazer N, Hashemi SM, Namaki S et al (2019b) Study of the immunomodulatory effects of osteogenic differentiated human dental pulp stem cells. Life Sci. https://doi.org/10.1016/j.lfs.2018.11.040 CrossRefPubMed

Institutes S, Wood R (2012) Concise review : Mesenchymal stem cells and translational medicine. Emerg Issues 1:51–58

Ionescu L, Byrne RN, van Haaften T et al (2012) Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. AJP Lung Cell Mol Physiol 303:L967–L977. https://doi.org/10.1152/ajplung.00144.2011 CrossRef

Jiang R (2011) Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes : a pilot study. Front Med 5:94–100. https://doi.org/10.1007/s11684-011-0116-z CrossRefPubMed

Jurewicz M, Yang S, Augello A et al (2010) Hyperglycemia in experimental type 1 diabetes. Diabetes. https://doi.org/10.2337/db10-0542 CrossRefPubMedPubMedCentral

Kavanagh H, Mahon BP (2011) Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells. Allergy Eur J Allergy Clin Immunol. https://doi.org/10.1111/j.1398-9995.2010.02509.x CrossRef

Kyurkchiev D (2014) Secretion of immunoregulatory cytokines by mesenchymal stem cells. World J Stem Cells 6:552. https://doi.org/10.4252/wjsc.v6.i5.552 CrossRefPubMedPubMedCentral

Lee RH, Seo MJ, Reger RL et al (2006) Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci USA 103:17438–17443. https://doi.org/10.1073/pnas.0608249103 CrossRefPubMed

Leibacher J, Henschler R (2016) Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells mesenchymal stem/stromal cells—an update. Stem Cell Res Ther 7:7CrossRef

Li Y, Liu H, Chen H, Li Y (2012) Adipose-derived mesenchymal stem cells ameliorate STZ-induced pancreas damage in type 1 diabetes. Biomed Mater Eng 22:97–103. https://doi.org/10.3233/bme-2012-0694 CrossRefPubMed

Liu M, Han ZC (2008) Mesenchymal stem cells : biology and clinical potential in type 1 diabetes therapy biological characterization of mesenchymal stem cells isolation and culture of human MSCs. J Cell Mol Med 12:1155–1168. https://doi.org/10.1111/j.1582-4934.2008.00288.x CrossRefPubMedPubMedCentral

Mackenzie TC, Flake AW (2001) Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep. Blood Cells Mol Dis 27(3):601–604CrossRef

Madec AM, Mallone R, Afonso G, Mrad EA (2009) Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia 52:1391–1399. https://doi.org/10.1007/s00125-009-1374-z CrossRefPubMed

Neshati Z, Matin MM, Bahrami AR, Moghimi A (2010) Differentiation of mesenchymal stem cells to insulin-producing cells and their impact on type 1 diabetic rats. J Physiol Biochem 66:181–187. https://doi.org/10.1007/s13105-010-0013-y CrossRefPubMed

Parekkadan B, Van Poll D, Suganuma K et al (2007) Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS ONE. https://doi.org/10.1371/journal.pone.0000941 CrossRefPubMedPubMedCentral

Pierro A, Eaton S, De Coppi P (2009) Amniotic fluid stem cell migration after intraperitoneal injection in pup rats: implication for therapy amniotic fluid stem cell migration after intraperitoneal injection in pup rats: implication for therapy. Pediatr Surg Int. https://doi.org/10.1007/s00383-009-2504-x CrossRef

Pouya S, Heidari M, Baghaei K et al (2018) Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis. Int Immunopharmacol 54:86–94. https://doi.org/10.1016/j.intimp.2017.11.001 CrossRefPubMed

Rahavi H, Hashemi SM, Soleimani M et al (2015) Adipose tissue-derived mesenchymal stem cells exert in vitro immunomodulatory and beta cell protective functions in streptozotocin-induced diabetic mice model. J Diabetes Res. https://doi.org/10.1155/2015/878535 CrossRefPubMedPubMedCentral

Sciences H, Ain A, Emirates UA, Medical S (2011) Concise review : Mesenchymal stem cell treatment of the complications of diabetes mellitus. Stem Cells. https://doi.org/10.1002/stem.556 CrossRef

Shim EK, Lee JS, Kim DE et al (2016) Autogenous mesenchymal stem cells from the vertebral body enhance intervertebral disc regeneration via paracrine interaction: an in vitro pilot study. Cell Transplant. https://doi.org/10.3727/096368916X691420 CrossRefPubMed

Sioud M, Mobergslien A, Boudabous A, Flisand Y (2011) Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins. Int J Oncol 38:385–390. https://doi.org/10.3892/ijo.2010.869 CrossRefPubMed

Soleymaninejadian E, Pramanik K, Samadian E (2012) Immunomodulatory properties of mesenchymal stem cells: cytokines and factors. Am J Reprod Immunol. https://doi.org/10.1111/j.1600-0897.2011.01069.x CrossRefPubMed

Svobodova E, Krulova M, Zajicova A et al (2012) The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population. Stem Cells Dev 21:901–910. https://doi.org/10.1089/scd.2011.0157 CrossRefPubMed

Tanaka F, Tominaga K, Ochi M et al (2008) Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats. Life Sci. https://doi.org/10.1016/j.lfs.2008.09.016 CrossRefPubMed

Timmers L, Lim SK, Hoefer IE et al (2011) Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res 6:206–214. https://doi.org/10.1016/j.scr.2011.01.001 CrossRefPubMed

Tse WT, Pendleton JD, Beyer WM et al (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75:389–397. https://doi.org/10.1097/01.TP.0000045055.63901.A9 CrossRefPubMed

Vija L, Farge D, Gautier J et al (2009) Mesenchymal stem cells: stem cell therapy perspectives for type 1 diabetes. Diabetes 35:85–93. https://doi.org/10.1016/j.diabet.2008.10.003 CrossRef

Wagner B, Henschler R, Mesenchymal ÁÁ (2013) Fate of intravenously injected mesenchymal stem cells and significance for clinical application. Adv Biochem Eng Biotechnol 130:19–37. https://doi.org/10.1007/10_2012_155 CrossRefPubMed

Walter MNM, Wright KT, Fuller HR et al (2010) Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fibroblast and keratinocyte scratch assays. Exp Cell Res 316:1271–1281. https://doi.org/10.1016/j.yexcr.2010.02.026 CrossRefPubMed

Wang Y, Zhang A, Ye Z et al (2009) Bone marrow-derived mesenchymal stem cells inhibit acute rejection of rat liver allografts in association with regulatory T-cell expansion. Transplant Proc. https://doi.org/10.1016/j.transproceed.2009.08.072 CrossRefPubMedPubMedCentral

Wang S, Li Y, Zhao J et al (2013) Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model. Biol Blood Marrow Transplant 19:538–546. https://doi.org/10.1016/j.bbmt.2013.01.001 CrossRefPubMed

Wang M, Liang C, Hu H et al (2016) Intraperitoneal injection (IP), intravenous injection (IV) or anal injection (AI)? Best way for mesenchymal stem cells transplantation for colitis. Sci Rep. https://doi.org/10.1038/srep30696 CrossRefPubMedPubMedCentral

Xu Y, Chen L, Wang R et al (2008) Mesenchymal stem cell therapy for diabetes through paracrine mechanisms. Med Hypotheses 71:390–393. https://doi.org/10.1016/j.mehy.2008.03.046 CrossRefPubMed

Yaochite J, Caliari-Oliveira C, de Souza L et al (2015) Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice. Stem Cell Res Ther 6:31. https://doi.org/10.1186/s13287-015-0017-1 CrossRefPubMedPubMedCentral

Yousefi F, Ebtekar M, Soleimani M et al (2013) Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE). Int Immunopharmacol. https://doi.org/10.1016/j.intimp.2013.07.016 CrossRefPubMed

Yousefi F, Ebtekar M, Soudi S et al (2016) In vivo immunomodulatory effects of adipose-derived mesenchymal stem cells conditioned medium in experimental autoimmune encephalomyelitis. Immunol Lett. https://doi.org/10.1016/j.imlet.2016.02.016 CrossRefPubMed

Zhang R, Liu Y, Yan K et al (2013) Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J Neuroinflamm. https://doi.org/10.1186/1742-2094-10-106 CrossRef

Zhao Y, Mazzone T (2010) Autoimmunity Reviews Human cord blood stem cells and the journey to a cure for type 1 diabetes. Autoimmun Rev 10:103–107. https://doi.org/10.1016/j.autrev.2010.08.011 CrossRefPubMed

Zheng ZH, Li XY, Ding J et al (2008) Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis. Rheumatology. https://doi.org/10.1093/rheumatology/kem284 CrossRefPubMed

Titel: Investigating the route of administration and efficacy of adipose tissue-derived mesenchymal stem cells and conditioned medium in type 1 diabetic mice
verfasst von: Seyed Mahmoud Hashemi
Zuhair Mohammad Hassan
Nikoo Hossein-Khannazer
Ali Akbar Pourfathollah
Sara Soudi
Publikationsdatum: 18.11.2019
Verlag: Springer International Publishing
Erschienen in: Inflammopharmacology / Ausgabe 2/2020
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-019-00661-x

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2020

Anti-inflammatory activities of Waltheria indica extracts by modulating expression of IL-1B, TNF-α, TNFRII and NF-κB in human macrophages

Pitfalls in meta-analysis

Deferoxamine regulates neuroinflammation and oxidative stress in rats with diabetes-induced cognitive dysfunction

Clindamycin inhibits nociceptive response by reducing tumor necrosis factor-α and CXCL-1 production and activating opioidergic mechanisms

Oridonin attenuates carrageenan-induced pleurisy via activation of the KEAP-1/Nrf2 pathway and inhibition of the TXNIP/NLRP3 and NF-κB pathway in mice

Anti-arthritic activity of ferulic acid in complete Freund’s adjuvant (CFA)-induced arthritis in rats: JAK2 inhibition